Celcuity (CELC) –
-
Form D/A Celcuity Inc.
-
Form 144 Celcuity Inc. Filed by: Buller Richard E
-
Form 4 Celcuity Inc. For: Apr 08 Filed by: Buller Richard E
-
Celcuity To Present at Upcoming Needham and Stifel Investor Conferences
-
Form 8-K Celcuity Inc. For: Mar 29
-
Form ARS Celcuity Inc. For: Dec 31
-
Form DEFA14A Celcuity Inc.
-
Form DEF 14A Celcuity Inc. For: Mar 28
-
Celcuity Inc (CELC) PT Raised to $25 at Craig-Hallum
-
Celcuity Inc (CELC) PT Raised to $24 at Needham
-
Form 10-K Celcuity Inc. For: Dec 31
-
Celcuity (CELC) Tops Q4 EPS by 16c
-
Form 8-K Celcuity Inc. For: Mar 27
-
Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
-
Form 4 Celcuity Inc. For: Mar 18 Filed by: Sullivan Brian F.
-
Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference Call
-
Celcuity to Participate in Leerink Partners Global Biopharma Conference 2024
-
Celcuity to Participate in Cowen’s 44th Annual Health Care Conference
-
Form 4 Celcuity Inc. For: Feb 21 Filed by: Buller Richard E
-
Celcuity Announces First Patient Dosed in Phase 1b/2 CELC-G-201 Clinical Trial of Gedatolisib for the Treatment of Metastatic Castration Resistant Prostate Cancer
-
Stifel Starts Celcuity Inc (CELC) at Buy, 'A Superior Breast Cancer Drug'
-
Celcuity (CELC) Appoints Eldon Mayer as Chief Commercial Officer
-
Celcuity Appoints Eldon Mayer as Chief Commercial Officer
-
Form 4 Celcuity Inc. For: Feb 13 Filed by: Hahne Vicky
-
Form 4 Celcuity Inc. For: Feb 13 Filed by: Laing Lance G.
-
Form SC 13G/A Celcuity Inc. Filed by: Venrock Healthcare Capital Partners III, L.P.
-
Form SC 13G/A Celcuity Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form SC 13G/A Celcuity Inc. Filed by: PERCEPTIVE ADVISORS LLC
-
Form SC 13G/A Celcuity Inc. Filed by: COMMODORE CAPITAL LP
-
Form SC 13G/A Celcuity Inc. Filed by: MORGAN STANLEY
-
Form SC 13G/A Celcuity Inc. Filed by: Soleus Capital Master Fund, L.P.
-
Form SC 13G/A Celcuity Inc. Filed by: Sullivan Brian F.
-
Form SC 13G/A Celcuity Inc. Filed by: Laing Lance G.
-
Form 4 Celcuity Inc. For: Jan 30 Filed by: Sullivan Brian F.
-
Form 4 Celcuity Inc. For: Jan 02 Filed by: Sullivan Brian F.
-
Form 4 Celcuity Inc. For: Dec 27 Filed by: Sullivan Brian F.
-
Form SC 13G Celcuity Inc. Filed by: PERCEPTIVE ADVISORS LLC
-
Form 4 Celcuity Inc. For: Dec 20 Filed by: Buller Richard E
-
Form 144 Celcuity Inc. Filed by: Buller Richard E
-
Form 4 Celcuity Inc. For: Dec 14 Filed by: Dalvey David
-
Form 4 Celcuity Inc. For: Dec 12 Filed by: Dalvey David
-
Form 4 Celcuity Inc. For: Dec 07 Filed by: Dalvey David
-
H.C. Wainwright Starts Celcuity Inc (CELC) at Buy
-
Form 144 Celcuity Inc. Filed by: Dalvey David
-
Celcuity Presents Preclinical Data on Therapeutic Effects of Gedatolisib in Breast Cancer Models at the 2023 San Antonio Breast Cancer Symposium
-
Form 8-K Celcuity Inc. For: Dec 01
-
Celcuity to Present Preclinical Data for Gedatolisib at the 2023 San Antonio Breast Cancer Symposium
-
Form 4 Celcuity Inc. For: Nov 28 Filed by: Furcht Leo
-
Form 424B3 Celcuity Inc.
-
Form EFFECT Celcuity Inc.
Back to CELC Stock Lookup